Characteristics of Covid-19 Disease in Multiple Sclerosis Patients

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Characteristics of Covid-19 Disease in Multiple Sclerosis Patients Publisher Pubmed

Barzegar M^{1, 2} ; Mirmosayyeb O^{1, 2, 3} ; Ghajarzadeh M³ ; Nehzat N^{1, 3} ; Vaheb S¹ ; Shaygannejad V^{1, 2} ; Vosoughi R⁴

Source: Multiple Sclerosis and Related Disorders Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Covid-19 and Disease-Modifying Therapies in Patients With Demyelinating Diseases of the Central Nervous System: A Systematic Review, Multiple Sclerosis and Related Disorders (2021)

2. Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic, Multiple Sclerosis and Related Disorders (2020)

3. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Sahraian (7)

Abdolreaza Naser Moghadasi (6)

Other Related Docs

4. Evaluation of the Rate of Covid-19 Infection, Hospitalization and Death Among Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)

5. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

6. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)

7. The Outcome of Covid-19 in Patients With a History of Taking Rituximab: A Narrative Review, Iranian Journal of Medical Sciences (2021)

8. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)

9. The Study of Covid-19 Infection Following Vaccination in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

10. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)

11. Multiple Sclerosis and Covid-19: A Retrospective Study in Iran, PLoS ONE (2023)

12. Implementing Coronavirus Disease 2019 Scale-Up Registry Protocol in National Multiple Sclerosis Registry System of Iran, Current Journal of Neurology (2021)

13. A Multi-Centre Longitudinal Study Analysing Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns During the Covid-19 Pandemic, Journal of Neurology (2024)

Style	Citing Format
MLA	Barzegar M, et al.. "Characteristics of Covid-19 Disease in Multiple Sclerosis Patients." Multiple Sclerosis and Related Disorders, vol. 45, no. , 2020, pp. -.
APA	Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, Vosoughi R (2020). Characteristics of Covid-19 Disease in Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders, 45(), -.
Chicago	Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, Vosoughi R. "Characteristics of Covid-19 Disease in Multiple Sclerosis Patients." Multiple Sclerosis and Related Disorders 45, no. (2020): -.
Harvard	Barzegar M et al. (2020) 'Characteristics of Covid-19 Disease in Multiple Sclerosis Patients', Multiple Sclerosis and Related Disorders, 45(), pp. -.
Vancouver	Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, et al.. Characteristics of Covid-19 Disease in Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders. 2020;45():-.
BibTex	@article{ author = {Barzegar M and Mirmosayyeb O and Ghajarzadeh M and Nehzat N and Vaheb S and Shaygannejad V and Vosoughi R}, title = {Characteristics of Covid-19 Disease in Multiple Sclerosis Patients}, journal = {Multiple Sclerosis and Related Disorders}, volume = {45}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Barzegar M AU - Mirmosayyeb O AU - Ghajarzadeh M AU - Nehzat N AU - Vaheb S AU - Shaygannejad V AU - Vosoughi R TI - Characteristics of Covid-19 Disease in Multiple Sclerosis Patients JO - Multiple Sclerosis and Related Disorders VL - 45 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract